Total or near-total loss of insulin-producing b-cells occurs in type 1 diabetes 1,2 . Restoration of insulin production in type 1 diabetes is thus a major medical challenge. We previously observed in mice in which b-cells are completely ablated that the pancreas reconstitutes new insulin-producing cells in the absence of autoimmunity 3 . The process involves the contribution of islet non-b-cells; specifically, glucagonproducing a-cells begin producing insulin by a process of reprogramming (transdifferentiation) without proliferation 3 . Here we show the influence of age on b-cell reconstitution from heterologous islet cells after near-total b-cell loss in mice. We found that senescence does not alter a-cell plasticity: a-cells can reprogram to produce insulin from puberty through to adulthood, and also in aged individuals, even a long time after b-cell loss. In contrast, before puberty there is no detectable a-cell conversion, although b-cell reconstitution after injury is more efficient, always leading to diabetes recovery. This process occurs through a newly discovered mechanism: the spontaneous en masse reprogramming of somatostatin-producing d-cells. The juveniles display 'somatostatin-to-insulin' d-cell conversion, involving dedifferentiation, proliferation and re-expression of islet developmental regulators. This juvenile adaptability relies, at least in part, upon the combined action of FoxO1 and downstream effectors. Restoration of insulin producing-cells from non-b-cell origins is thus enabled throughout life via dor a-cell spontaneous reprogramming. A landscape with multiple intra-islet cell interconversion events is emerging, offering new perspectives for therapy.
Total or near-total loss of insulin-producing b-cells occurs in type 1 diabetes 1, 2 . Restoration of insulin production in type 1 diabetes is thus a major medical challenge. We previously observed in mice in which b-cells are completely ablated that the pancreas reconstitutes new insulin-producing cells in the absence of autoimmunity 3 . The process involves the contribution of islet non-b-cells; specifically, glucagonproducing a-cells begin producing insulin by a process of reprogramming (transdifferentiation) without proliferation 3 . Here we show the influence of age on b-cell reconstitution from heterologous islet cells after near-total b-cell loss in mice. We found that senescence does not alter a-cell plasticity: a-cells can reprogram to produce insulin from puberty through to adulthood, and also in aged individuals, even a long time after b-cell loss. In contrast, before puberty there is no detectable a-cell conversion, although b-cell reconstitution after injury is more efficient, always leading to diabetes recovery. This process occurs through a newly discovered mechanism: the spontaneous en masse reprogramming of somatostatin-producing d-cells. The juveniles display 'somatostatin-to-insulin' d-cell conversion, involving dedifferentiation, proliferation and re-expression of islet developmental regulators. This juvenile adaptability relies, at least in part, upon the combined action of FoxO1 and downstream effectors. Restoration of insulin producing-cells from non-b-cell origins is thus enabled throughout life via dor a-cell spontaneous reprogramming. A landscape with multiple intra-islet cell interconversion events is emerging, offering new perspectives for therapy.
To determine how ageing affects the mode and efficiency of b-cell reconstitution after b-cell loss, we administered diphtheria toxin (DT) to adult (2-month-old) or aged (1-and 1.5-year-old) RIP-DTR mice, whose b-cells bear DT receptors 3 , and followed them for up to 14 months. Collectively, we found that a-to-b-cell conversion is the main mechanism of insulin cell generation after massive b-cell loss in adult post-pubertal mice, whether middle-aged or very old, and that a-cells are progressively recruited into insulin production with time (Extended Data Fig. 1 and Supplementary Tables 1-5) .
We focused on regeneration potential during early postnatal life by inducing b-cell ablation before weaning, at 2 weeks of age ( Fig. 1a ). We found that prepubescent mice rapidly recover from diabetes after neartotal b-cell loss: 4 months later all mice were almost normoglycaemic, thus displaying a faster recovery relative to adults ( Fig. 1b and Extended Data Fig. 2a , b; see also Extended Data Fig. 1a ).
Histologically, 99% of b-cells were lost at 2 weeks after DT administration ( Fig. 1c) . The b-cell number increased by 45-fold 4 months after ablation, representing 23% of the normal age-matched b-cell mass ( Fig. 1c and Supplementary Table 6 ) and correlating with recovery of normoglycaemia 1 .
All animals remained normoglycaemic for the rest of their life (Supplementary Table 6 ). Mice were neither intolerant to glucose nor insulin resistant during the period of analysis, up to 15 months after injury (Extended Data Fig. 2c-e ).
We investigated whether the new insulin 1 cells were reprogrammed a-cells, as in adults, using glucagon-rtTA; TetO-Cre; R26-YFP; RIP-DTR pups (Fig. 1d ). We observed that almost no insulin 1 cells co-expressed yellow fluorescent protein (YFP) or glucagon (Supplementary Table 7 ), indicating that a-cells do not reprogram in juveniles.
We further explored the age-dependency of rescue after near-total b-cell loss. To this aim, normoglycaemic 5-month-old mice, which had recovered from b-cell loss at 2 weeks of age, were re-administered DT to ablate the regenerated insulin 1 cells. One month following the second ablation, 30% of the insulin-containing cells also contained glucagon (Extended Data Fig. 2f and Supplementary Table 8 ), like b-cell-ablated adults (Extended Data Fig. 1k ), confirming that the pre-pubertal regeneration mechanism is restricted temporally.
We measured proliferation rates at different time-points over 2 months of regeneration. The proportion of Ki67-labelled insulin 1 cells was very low (Extended Data Fig. 2g and Supplementary Table 9 ), indicating that neither escaping b-cells nor regenerated insulin 1 cells proliferate during this period. However, there was a transient 3.5-fold increase in the number of insular Ki67 1 cells 2 weeks after ablation, unlike in adult animals (Extended Data Fig. 2h and Supplementary Table 10 ). Replicating cells were hormone-negative, chromogranin-A-negative, and were not lineage traced to either aor escaping b-cells (Extended Data Fig. 2i , j).
Coincident with the peak of islet cell proliferation, we noticed in pups a 4.5-fold decrease in the number of somatostatin (Sst)-producing d-cells (from 13 to 3 d-cells per islet section; Extended Data Fig. 3a and Supplementary Table 11 ) and a 76-fold decrease of Sst transcripts (Extended Data Fig. 3b ), without any indication of increased islet cell death. We therefore lineage traced d-cells and observed that regenerated insulinproducing cells were dedifferentiated d-cells. At 2 months of age in Sst-Cre; R26-YFP; RIP-DTR mice, about 81% of d-cells were YFP 1 in the absence of b-cell ablation, whereas aand b-cells were labelled at background levels (0.9% for b-cells and 0.2% for a-cells; Extended Data Fig. 3c, d and Supplementary Table 12 ). During b-cell reconstitution in pups, 2 weeks after b-cell ablation, 80% of YFP 1 cells were proliferating (Ki67 1 ) and Sst-negative ( Fig. 2a, b and Supplementary Table 13 ), while most Ki67 1 cells were YFP-labelled (85%; Supplementary Table 14 ).
These observations suggest that in b-cell-ablated pre-pubertal mice most d-cells undergo a loss of Sst expression and enter the cell cycle.
We further investigated the fate of proliferating dedifferentiated d-cells. At 1.5 months post-ablation, most insulin 1 cells expressed YFP (90%), indicating their d-cell origin (Fig. 2c, d and Supplementary Table 15 ). Furthermore, in contrast to non-ablated age-matched controls, where all YFP 1 cells were Sst 1 (.99%), about half of YFP 1 cells were insulin 1 after 1.5 months of regeneration (45%; Fig. 2e and Supplementary  Table 16 ). This reveals that half of the progeny of dedifferentiated d-cells becomes insulin expressers. Bihormonal Sst 1 /insulin 1 cells were rare ( Supplementary Table 17 ).
Combined, these observations show that at the cell population level, each dedifferentiated d-cell yields one insulin expresser cell and one Sst 1 cell (Extended Data Fig. 4 ).
We confirmed with two other assays that regeneration and diabetes recovery in juvenile mice are d-cell-dependent: by inducing b-cell destruction with streptozotocin (STZ) instead of DT (Extended Data Fig. 5a -c), and by co-ablating band d-cells simultaneously in Sst-Cre; R26-YFP; R26-iDTR; RIP-DTR pups. In the absence of d-cells there was no insulin 1 cell regeneration, and no recovery ( Fig. 2f ).
In adults, d-cells neither dedifferentiated nor proliferated after b-cell ablation (Extended Data Fig. 5d , e and Supplementary Table 20 ). Nevertheless, like a-cells, a few d-cells reprogrammed into insulin production, so that after 1.5 month of regeneration 17% of the rare insulin-producing cells were YFP 1 , that is, d-cell-derived (Extended Data Fig. 5f-h and Supplementary Tables 21, 22 ).
By transplanting Sst-Cre; R26-YFP; RIP-DTR juvenile islets into adult wild-type mice we observed that, following b-cell ablation, the newly formed insulin 1 cells were reprogrammed d-cells, thus showing that the pup-specific regeneration is intrinsic to islets (Extended Data Fig. 6 ).
Contrary to b-cells in age-matched adult mice, d-cell-derived insulin 1 cells replicated transiently (Extended Data Fig. 7a and Supplementary  Table 23 ); the b-cell mass thus reached between 30% to 69% of the normal values, and remained stable for life (see earlier; Supplementary Table 6 ).
We characterized the d-cell-derived insulin 1 cells at the gene expression level by quantitative polymerase chain reaction (qPCR). We first compared islets isolated 2 weeks after b-cell ablation or after recovery (4 months post-DT) with age-matched control islets. Expression of all the b-cell-specific markers tested was robustly increased in recovered mice (Extended Data Fig. 7b ). We also compared regenerated insulin 1 cells with native b-cells using sorted mCherry 1 cells obtained from either recovered or unablated age-matched (4.5-month-old) insulin-mCherry; RIP-DTR mice (Extended Data Fig. 7c ). The two cell populations were very similar (Extended Data Fig. 7d ), yet the d-cell-derived replicating b-cells displayed a potent downregulation of cyclin-dependent kinase Table 6 ). Percentages refer to b-cell mass relative to age-matched unablated controls. DAPI, 49,6-diamidino-2-phenylindole. d, a-Cell tracing in pups. DOX, doxycycline. Scale bars, 20 mm.
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inhibitors and regulators (Extended Data Fig. 7e , f). This suggests that reconstituted insulin 1 cells are like b-cells with transient proliferation capacity. Future studies will establish whether reconstituted (d)b-like cells are true equivalents to native b-cells. qPCR and lineage-tracing analyses on islets isolated from pups at different regeneration time-points, together with Ngn3 (also known as Neurog3) knockout induction after b-cell ablation, revealed that Ngn3 transcription is required for the d-to-insulin 1 cell conversion to occur (Extended Data Fig. 8a-k and Supplementary Tables 24-29 ). Of note, the brief expression of Ngn3 is a feature of islet precursor cells in the embryonic pancreas 4 . Together, these observations are compatible with a model in which b-cell reconstitution after ablation in juveniles occurs following a defined sequence of events: d-cells dedifferentiate, replicate once, and then half of the progeny activates Ngn3 expression before insulin production ( Fig. 2g ). This was tested in a combined double lineage-tracing experiment using Sst-Cre; R26-Tomato; Ngn3-YFP; RIP-DTR mice. Six weeks after b-cell ablation, insulin 1 cells in juveniles were Tomato 1 / YFP 1 (Extended Data Fig. 8k ).
One key reprogramming and cell cycle entry player is FoxO1, a transcription factor whose downregulation triggers Ngn3 expression in human fetal pancreatic explants 5 and favours insulin production in Ngn3 1 enteroendocrine progenitors 6 . FoxO1, usually in cooperation with TGF-b/ SMAD signalling 7, 8 , inhibits cell proliferation through the transcriptional regulation of cell cycle inhibitors and activators 9 , and is involved in cellular senescence 7 (Extended Data Fig. 9a ). We next explored the FoxO1 molecular network in purified adult or juvenile d-cells before and after (1 week) b-cell ablation, using Sst-Cre; R26-YFP; RIP-DTR mice.
d-cells displayed divergent regulation of Foxo1 in injured juvenile and adult mice. Consistent with Foxo1 downregulation in juvenile d-cells, Pdk1 and Akt (also known as Akt2) levels were increased, Cdkn1a (also known as p21) and Cdkn2b (also known as p15Ink4b) were downregulated, and Cks1b, Cdk2 and Skp were upregulated ( Fig. 3a) , which is compatible with the proliferative capacity of juvenile d-cells after b-cell ablation. The opposite was found in the d-cells of ablated adults ( Fig. 3a and Extended Data Fig. 9b ).
Moreover, in d-cells of juveniles, but not in adults, there was a robust upregulation of BMP1/4 downstream effectors ( Fig. 3b) 10, 11 . Inversely, TGF-b pathway genes were upregulated in d-cells of regenerating adults (Fig. 3b ), which is compatible with the senescence scenario 7 involving PI3K/FoxO1 and TGF-b/SMAD cooperation to maintain differentiation and cycle arrest (Extended Data Fig. 9a, b ).
In summary, PI3K/AKT and SKP2/SCF pathways potentially cooperate to downregulate Foxo1 in d-cells of regenerating juveniles. Also, upregulation of BMP effectors (Id1 and Id2) could contribute to d-cell dedifferentiation and proliferation, as observed in other systems 10, 11 (Fig. 3c ). Conversely, the PI3K/AKT pathway remained downregulated in d-cells of ablated adults, which would allow FoxO1 to impede proliferation and dedifferentiation, probably through partnership with previously described SMADs 12 (Extended Data Fig. 9b ).
We next checked whether a transient FoxO1 inhibition in adult mice would lead to a juvenile-like d-to-b-cell conversion. Indeed, inactivation of FoxO1 in b-cells causes their dedifferentiation 13 . Here, Sst-Cre; R26-YFP; RIP-DTR b-cell-ablated adult mice were given a FoxO1 inhibitor (AS1842856) for 1 week, either immediately following ablation (Fig. 3d ) or 1 month later (Extended Data Fig. 10f and Supplementary Tables 37-39) 14, 15 . While FoxO1 inhibition in non-ablated controls had a minimal effect on insulin expression (Extended Data Fig. 10a-d and Supplementary  Tables 30-32) , regeneration in diabetic mice was improved: insulin 1 cells were more abundant (11-fold; Fig. 3e, f and Supplementary Table 33 ), and were reprogrammed d-cells (93% were YFP 1 , Fig. 3g and Supplementary Table 34 ). One-fourth of the YFP 1 cells expressed insulin only (Fig. 3h , Extended Data Fig. 10e and Supplementary Tables 35, 36 ), revealing that, like in juveniles, an important fraction of d-cells had converted to insulin production.
These results support the involvement of a regenerative FoxO1 network and confirm that d-cell conversion can be pharmacologically induced in diabetic adults. FoxO1 blockade has a pleiotropic effect: inhibition of hepatic gluconeogenesis 14, 15 and, as we have shown, promotion of d-cell reprogramming.
A century ago Morgan coined the terms 'epimorphosis' and 'morphallaxis' to designate, respectively, regeneration involving either cell dedifferentiation and proliferation or direct conversion from one cell type into another without proliferation 16 . Here we report in mammals an age-dependent switch ('adult transition') between epimorphic regeneration during youth, and a less efficient yet persistent throughout life proliferation-independent morphallactic mechanism.
Our findings uncover a novel role for d-cells; perhaps Sst 1 cells in the stomach, intestine or hypothalamus share the same capabilities. Intraislet cell plasticity triggered by the disappearance of b-cells is influenced by age: the proliferation decline in ageing cells 17 would explain the need for an adult transition. Although less efficient, a-cell plasticity remains long-time after b-cell loss since it is proliferation-independent. 
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These phenomena might be translatable to humans, as there is efficient b-cell regeneration in children with type 1 diabetes or after pancreatectomy 9, 18, 19 , and glucagon/insulin bihormonal human cells have been described upon epigenetic manipulation ex vivo 20 , and in diabetic patients 21, 22 . Knowing also that only a small fraction of the a-cell population is sufficient to maintain glucagon signalling 23 Author Information Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to P.H. (pedro.herrera@unige.ch). Table 1 ). Two-month-old: n 0.5 mpa 5 4; n 1 mpa 5 4; n 7 mpa 5 4; 1-year-old: n 0.5 mpa 5 5, n 1 mpa 5 5, n 7 mpa 5 5, n 14 mpa 5 8; 1.5-year-old: n 0.5 mpa 5 3; n 1 mpa 5 3; n 7 mpa 5 3, n 14 mpa 5 8. f, b-Cell proliferation is very low in aged mice, whether control (1.5%; n 5 8; 39,790 insulin 1 -cells scored) or ablated (0.2%; n 5 6; 938 insulin 1 -cells scored) (Supplementary Table 2 ). g, Proportion of insulin 1 cells also containing glucagon after DT is not different between groups (Supplementary Table 3 ). Control: n 2-month-old 5 3; n 1-year-old 5 3; n 1.5-year-old 5 3; 0.5 mpa: n 2-month-old 5 5; n 1-year-old 5 5; n 1.5-year-old 5 6; 1 mpa: n 2-month-old 5 4; n 1-year-old 5 6; n 1.5-year-old 5 4; 7 mpa: n 2-month-old 5 5; n 1-year-old 5 5; n 1.5-year-old 5 6. One-way ANOVA (P 5 0.6796, 0.4297, 0.9266, 0.2411); note that 40% of the cells containing insulin at 1 mpa also contained glucagon. The proportion of glucagon 1 /insulin 1 cells remains constant between 0.5 and 7 mpa, while the number of insulin 1 cells increases with time (e; Supplementary Table 1 ), suggesting that there is a cumulative recruitment of a-cells into insulin production. h, Islet with YFP 1 /glucagon 1 /insulin 1 cells in 1-year-old glucagon-rtTA; TetO-Cre; R26-YFP; RIP-DTR mice, 7 mpa; rtTA expression allows the selective irreversible YFP labelling of adult a-cells upon administration of doxycycline (DOX) before b-cell ablation. i, Proportion of YFP-labelled insulin-expressing cells in DOX-treated mice. Eighty per cent of insulin 1 cells are YFP 1 after 7 mpa, in all age groups (Supplementary Table 4 ). Control: n 2-month-old 5 3; n 1-year-old 5 3; n 1.5-year-old 5 3; 1 mpa: n 2-month-old 5 5; n 1-year-old 5 3; n 1.5-year-old 5 3; 7 mpa: n 2-month-old 5 5; n 1-year-old 5 5; n 1.5-year-old 5 5. One-way ANOVA (P 5 0.9417, 0.8910, 0.9641). j, k, YFP 1 /glucagon 1 /insulin 1 cells at 7 mpa, following DOX pulse-labelling at 5.5 months after b-cell loss ( Supplementary Table 5 ). Control: n 1-year-old 5 5; n 1.5-year-old 5 5; 7 mpa: n 1-year-old 5 5; n 1.5-year-old 5 5; Welch's correction (P 5 0.8272, 0.8926), Mann-Whitney (P 5 0.9444). On average, 15% of the insulin 1 cells found were YFP labelled, some of which no longer contained glucagon as in j, bottom row. Note the decreased proportion of YFP-labelled insulin 1 cells when a-cells are tagged late after ablation (from 80% to 15%; compare i and k), and the presence of YFP-labelled insulin 1 /glucagon-negative cells in the latter situation (j), suggesting that bihormonal a-cells slowly but gradually lose glucagon gene activity. Scale bars, 20 mm. Error bars show s.d.
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Extended Data Figure 2 | Diabetes recovery in pre-pubertal mice.
a, Evolution of glycemia (AuC) between 2.5 and 4 mpa, in pups and adults (see Fig. 1b ) (Welch's test, P 5 0.0188). b, qPCR of insulin 2 messenger RNA after b-cell ablation; insulin 2 transcripts are 25-fold more abundant in pups than in adults at 2 mpa (n 5 3 mice per group, each individual sample was run in triplicate in each reaction for a total of three independent reactions). Built-in Welch's test (P 5 0.0134, 0.0049). Error bars show s.d. c, Glucose tolerance tests (IPGTT) for DT-treated (4.5 mpa, n 5 4) and age-matched controls (n 5 4); note the fold increase between glucose injection and the glycaemic peak during IPGTT for each animal, and fold decrease between glycaemic peak and T120 (two-tailed unpaired t-test, P I 5 0.5836, P II 5 0.4937). d, Plasma insulin at time point (in min) T0, T15 and T30 during the IPGTT. Control: n 5 4; DT: n 5 4; two-tailed paired t-test (P 5 0.0008). e, Insulin tolerance tests (ITT) performed 1.5 years after b-cell ablation at 2 weeks of age. Controls: n 5 7; DT: n 5 10. f, 4.5 months after b-cell ablation (at 2 weeks), three mice became normoglycaemic and received a second treatment with DT. Ablation of regenerated insulin 1 cells in recovered mice leads to the appearance of glucagon 1 /insulin 1 cells, corresponding to the type of 'a-cell-dependent' regeneration observed in adults (31% of insulin 1 cells also contained glucagon; Supplementary Table 8 ). Arrow indicates glucagon 1 /insulin 1 bihormonal cell.
Error bars show standard error of the mean (s.e.m.). g, b-cell proliferation is very low in regenerating pups ( Supplementary Table 9 ). Control: n 1-month-old 5 3, 6,006 insulin 1 -cells scored; n 2-month-old 5 3, 6,358 insulin 1cells scored; DT: n 0.5 mpa 5 5, 412 insulin 1 -cells scored; n 1.5 mpa 5 3, 675 insulin 1 -cells scored; Welch's test (P 5 0.1197, P 5 0.0688). Error bars show s.e.m. h, Islet cell proliferation is increased (3.5-fold; Ki67 1 cells) in islets of DT-treated pups at 0.5 mpa. Control: n 1-month-old 5 3, 95 islets scored; n 1.5-month-old 5 3, 94 islets scored; n 2-month-old 5 3, 90 islets scored; n 2.5-month-old 5 3, 89 islets scored; n 3-month-old ctrl 5 3, 91 islets scored; n 3.5-month-old 5 3, 93 islets scored; n 18.5-month-old 5 3, 83 islets scored; n 19-month-old ctrl 5 3, 83 islets scored; n 19.5-month-old 5 3, 88 islets scored; DT (2-week-old): n 0.5 mpa 5 6, 333 islets scored; n 1 mpa 5 3, 91 islets scored; n 1.5 mpa 5 3, 90 islets scored; DT (2-month-old): n 0.5 mpa 5 3, 76 islets scored; n 1 mpa 5 3, 77 islets scored; n 1.5 mpa 5 3, 81 islets scored; DT (1.5-year-old): n 0.5 mpa 5 3, 74 islets scored; n 1 mpa 5 3, 81 islets scored; n Table 18 ). n STZ 5 87 islets, 3 mice; n DT 5 361 islets, 4 mice. Welch's test (inter-islet P , 0.0001; inter-individual P 5 0.0109), Mann-Whitney (P , 0.001). c, The number of YFP 1 /insulin 1 cells per islet section at 1.5 mpa is not significantly different between the two b-cell ablation methods ( Supplementary Table 19 ). n STZ 5 88 islets, 3 mice; n DT 5 193 islets, 7 mice. Welch's test (P 5 0.4786). d, d-cell numbers per islet section in controls (n 5 3, 174 islets scored), 0.5 mpa (n 5 4, 140 islets scored) and 1 mpa (n 5 3, 86 islets scored). Unpaired t-test, two-tailed (P 5 0.6386; P 5 0.5406). e, Immunofluorescence for YFP and Ki67 2 weeks (0.5 mpa) after DT, in Sst-Cre; R26-YFP; RIP-DTR mice. f, Experimental design for d-cell tracing in b-cell-ablated Sst-Cre; R26-YFP; RIP-DTR mice at 2 months of age, and immunofluorescence for Sst, YFP and insulin at 1.5 mpa. Arrow indicates YFP 1 /insulin 1 /Sst 2 cell. g, At 1.5 mpa, 17% of insulin 1 cells co-express YFP versus almost 100% in ablated prepubescent mice. Control: n 5 4; DT: n 5 8; unpaired t-test, two-tailed (P 5 0.0462). h, At 1.5 mpa, 98% of the YFP 1 cells are Sst 1 , and 1% are insulin 1 cells (versus 44% in mice ablated before puberty; n 5 8, unpaired t-test, two-tailed). Scale bars, 20 mm. Error bars show s.d.
